CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 23 enrolled
Drug / intervention
Customized version of DAVID device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04188834
NCT04188834N/ACompleted

Neurophysiological and Behavioral Effects of Sensory Flicker and Electrical Flicker Stimulation

Emory University·interventional·Posted Dec 6, 2019·Updated Mar 26, 2024

In Brief

A clinical study evaluating Customized version of DAVID device and Blackrock CereStim for Brain Diseases. Completed, enrolled 23 participants across 1 site.

Detailed Summary

The study will evaluate whether sensory flicker can modulate neural activity of deep brain regions in humans, and whether it can have relevant effects on behavior. Moreover, it will compare those effects to the gold-standard method of modulating brain circuits, direct electrical stimulation of the brain (the same mechanism as deep brain stimulation), using a powerful within-subjects design.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBrain Diseases
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 6, 2019
Enrollment StartJan 10, 2020
Primary CompletionNov 22, 2022
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 6.6 years ago

Interventions

Customized version of DAVID devicedevice

A customized version of the DAVID device will be used to expose participants to sensory flicker. The device consists of opaque glasses containing LEDs to present flickering light, as well as earbuds or headphones to present flickering sound.

Blackrock CereStimdevice

The Blackrock CereStim is a fully programmable neurostimulator. The current pulses generated by the Blackrock CereStim are intended to stimulate neurons in proximity to a set of electrodes.